Resumen
Canine mammary inflammatory carcinoma cell line. The present invention relates to an established cell line of canine mammary inflammatory carcinoma, of triple negative basal epithelial cells. The invention also relates to a method for obtaining stable xenotransplantation of canine mammary inflammatory carcinoma in experimental animals, and to the use of the cell line and xenotransplantation in the study of canine mammary inflammatory carcinoma as well as of human inflammatory mammary carcinoma. And its use to identify in vitro therapeutically useful compounds for the treatment of human mammary inflammatory cancer. It also refers to a kit for the in vitro study of canine bmi and/or human ibc and potentially usable drugs against human ibc, which includes the cell line of the invention. (Machine-translation by Google Translate, not legally binding)